[Risk of infection by biologics] (Q81402998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

[Risk of infection by biologics] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

author name string

J U Holle

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

S Schinke

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

W L Gross

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

number of pages

10

1 reference

Zeitschrift fuer Rheumatologie

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

295-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528697 AND SRC:MED&resulttype=core&format=json

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

8 January 2020

cites work

1 reference

12 December 2020

Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection

1 reference

12 December 2020

The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease

1 reference

12 December 2020

Effect of tumour necrosis factor antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection

1 reference

12 December 2020

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

12 December 2020

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment

1 reference

12 December 2020

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

1 reference

12 December 2020

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

1 reference

12 December 2020

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection

1 reference

12 December 2020

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

1 reference

12 December 2020

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

1 reference

12 December 2020

Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor- Antagonists

1 reference

12 December 2020

Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay

1 reference

12 December 2020

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

12 December 2020

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

1 reference

12 December 2020

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

1 reference

12 December 2020

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection

1 reference

12 December 2020

Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial

1 reference

12 December 2020

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

1 reference

12 December 2020

Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists

1 reference

12 December 2020

The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial

1 reference

12 December 2020

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

1 reference

12 December 2020

Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice

1 reference

12 December 2020

Association of infections and tuberculosis with antitumor necrosis factor alpha therapy.

1 reference

12 December 2020

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

1 reference

12 December 2020

Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system

1 reference

12 December 2020

Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy

1 reference

12 December 2020

Fungal infections complicating tumor necrosis factor alpha blockade therapy.

1 reference

12 December 2020

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

12 December 2020